These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16622409)

  • 1. Carbohydrate recognition by Clostridium difficile toxin A.
    Greco A; Ho JG; Lin SJ; Palcic MM; Rupnik M; Ng KK
    Nat Struct Mol Biol; 2006 May; 13(5):460-1. PubMed ID: 16622409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
    Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
    Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of Le(A)-LacNAc pentasaccharide as a ligand for Clostridium difficile toxin A.
    Zhang P; Ng K; Ling CC
    Org Biomol Chem; 2010 Jan; 8(1):128-36. PubMed ID: 20024143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of Clostridium difficile toxins to human milk oligosaccharides.
    El-Hawiet A; Kitova EN; Kitov PI; Eugenio L; Ng KK; Mulvey GL; Dingle TC; Szpacenko A; Armstrong GD; Klassen JS
    Glycobiology; 2011 Sep; 21(9):1217-27. PubMed ID: 21610194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Oligosaccharides in Human Milk Bound onto the Toxin A Carbohydrate Binding Site of Clostridium difficile.
    Nguyen TT; Kim JW; Park JS; Hwang KH; Jang TS; Kim CH; Kim D
    J Microbiol Biotechnol; 2016 Apr; 26(4):659-65. PubMed ID: 26718473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
    D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
    FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes.
    Rupnik M
    FEMS Microbiol Rev; 2008 May; 32(3):541-55. PubMed ID: 18397287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface association.
    Demarest SJ; Salbato J; Elia M; Zhong J; Morrow T; Holland T; Kline K; Woodnutt G; Kimmel BE; Hansen G
    J Mol Biol; 2005 Mar; 346(5):1197-206. PubMed ID: 15713474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
    Genth H; Dreger SC; Huelsenbeck J; Just I
    Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.
    Ho JG; Greco A; Rupnik M; Ng KK
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18373-8. PubMed ID: 16344467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
    Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
    PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution and density of Clostridium difficile toxin receptors on the intestinal mucosa of neonatal pigs.
    Keel MK; Songer JG
    Vet Pathol; 2007 Nov; 44(6):814-22. PubMed ID: 18039894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Fanning S; Kyne L
    Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region.
    Faust C; Ye B; Song KP
    Biochem Biophys Res Commun; 1998 Oct; 251(1):100-5. PubMed ID: 9790914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases.
    von Eichel-Streiber C; Sauerborn M; Kuramitsu HK
    J Bacteriol; 1992 Oct; 174(20):6707-10. PubMed ID: 1307487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a neutralizing antibody helps identify structural features critical for binding of
    Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
    J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
    [No Abstract]   [Full Text] [Related]  

  • 17. Processing of Clostridium difficile toxins.
    Giesemann T; Egerer M; Jank T; Aktories K
    J Med Microbiol; 2008 Jun; 57(Pt 6):690-696. PubMed ID: 18480324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
    Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
    Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective Sequestration of Clostridium difficile Protein Toxins by Calcium Aluminosilicate.
    Sturino JM; Pokusaeva K; Carpenter R
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7178-83. PubMed ID: 26149988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
    Jank T; Giesemann T; Aktories K
    Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.